The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Revenue is up 23% whereas Profit After Tax expands 29% for the company
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
